01.28.21 When Pharmaceutical Automation Projects Fail: Averting Disaster Through Risk Assessment
With the spread of SARS-CoV-2 (COVID-19) intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring life-saving drugs to market. Attend this webinar to learn more about bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy and the impacts and comparisons of classic platforms vs. new-generation platforms. And more!
By Tim Sandle, Ph.D., Bio Products Laboratory Ltd.
Automation does not always result in success, and poor automation can be as damaging to the pharmaceutical organization as no automation at all. This article addresses what happens when automation goes wrong and how mistakes can be avoided by adopting a risk-centric approach.
Pelican BioThermal Announces Korean Air Cargo Partnership
™ on Demand global network in support of pandemic response
Pelican BioThermal, the global name in temperature controlled packaging, announces its new partnership with Korean Air Cargo, the latest in the company’s expanding network of worldwide alliances.
Through the partnership, the Asia airline will offer Pelican BioThermal’s high-performing shipper solutions direct to the airline’s customers for the first time through the Crēdo
™ on Demand rental program. The announced agreement gives the partner airline’s customers rapid access to Pelican BioThermal’s newly expanded range of temperature controlled packaging to cover both deep frozen and frozen applications, which include dry ice and phase change material (PCM) coolants, covering parcel and bulk sizes for single or multi-use/reusable, including rental through the Crēdo